Profil:
Diagnostyka SAUPDATE: Diagnostyka medical posts PLN 78.1 mln attributable net profit in Q3 2025, compared to PLN 65.3 mln consensus
Listed medical diagnostic service provider Diagnostyka posted PLN 78.1 million (EUR 18.5 mln) attributable net profit in the third quarter of 2025, which represents a 19.6 percent increase year on year, the company's financial report showed. The PAP Biznes consensus forecast was PLN 65.3 million (EUR 15.4 mln) in profit.
"A sharp increase in the number of tests performed, a steady rise in the average price in laboratory diagnostics, and further expansion in imaging diagnostics -these were the main drivers of Diagnostyka's very strong third'quarter results. And the reasons why we can say once again that we have completed another successful quarter," said CEO Jakub SwadZba, quoted in the press release.
In the third quarter of 2025, Diagnostyka recorded an increase in test volumes to 43 million, up 10.9 percent year on year. At the same time, the average test price rose by 14.5 percent year on year, driven by a favourable product mix and the consolidation of imaging-diagnostics companies.
"The key driver of the improvement in financial performance remained organic growth, supported by the consistent execution of our M&A strategy. A high level of free cash flow maintains our ability to finance development and acquisitions from our own resources, while also providing comfortable room to continue sharing profits with shareholders. We are keeping debt under control, maintaining a net-debt-to-EBITDA ratio at a very safe 1.7x," added deputy CEO Pawel Chytla.
A strategic priority for the group in the coming years remains expansion in the imaging-diagnostics market.
"Imaging diagnostics remains one of the most dynamically growing segments of the medical market, which is why we continue to strengthen our position there. The market is still highly fragmented, creating room for further consolidation. We plan to continue selective acquisitions, focusing on companies that enhance our capabilities and scale," the CEO added.
PLN mln
| 3Q2025 | results | consensus | difference | y/y | q/q | YTD 2025 | y/y |
| revenues | 615.1 | 606.2 | 1.5% | 26.6% | 3.7% | 1803.3 | 23.9% |
| EBITDA | 152.2 | 152.3 | 0.0% | 24.3% | -0.5% | 464.4 | 22.8% |
| EBIT | 100.7 | 102.5 | -1.8% | 22.1% | -2.0% | 315.7 | 21.5% |
| attrib. net profit | 78.1 | 65.3 | 19.6% | 52.5% | 22.3% | 214.7 | 25.5% |
| EBITDA margin | 24.7% | 24.9% | -0.20 | -0.44 | -1.03 | 25.75% | -0.22 |
| EBIT margin | 16.4% | 16.8% | -0.47 | -0.60 | -0.95 | 17.51% | -0.34 |
| net margin | 12.7% | 10.8% | 1.86 | 2.16 | 1.94 | 11.91% | 0.15 |
---
doa/ nl/
